NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal Antengene (SEHK: 6996.HK) presents ATG-125, ATG-106, and ATG-112 preclinical data at AACR 2026. Read what the results mean for its pipeline strategy. byVenkateshApril 18, 2026